Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease

BACKGROUND: Low-dose oral azithromycin therapy is recommended as a preventive treatment for acute exacerbations of COPD. However, the overall benefit–harm balance of this treatment has not been well studied. METHODS: A probabilistic Markov model of COPD was created to simulate the course of COPD ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadian, Safa, Sin, Don D, Lynd, Larry, Harrison, Mark, Sadatsafavi, Mohsen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Chronic Obstructive Pulmonary Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606520/
https://www.ncbi.nlm.nih.gov/pubmed/34836921
http://dx.doi.org/10.1136/thoraxjnl-2021-217962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606520/
https://www.ncbi.nlm.nih.gov/pubmed/34836921
http://dx.doi.org/10.1136/thoraxjnl-2021-217962

Ejemplares similares